S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 23 of 23

Issue Date	Title / Author(s) / Citation	File
2004-02	Transforming growth factor-β1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells Kim, Sang Gyun; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Kim, Noe Kyeong; Hong, Seung Hwan; Bang, Yung-Jue Molecular Biology of the Cell, Vol.15 No.2, pp.420-434	DOI
2005-08	Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor Im, Seock-Ah; Kim, Sung-Bae; Lee, Moon Hee; Im, Young-Hyuck; Lee, Kyung Gee; Song, Hong-Suk; Lee, Myung-Ah; Lee, Junglim; Lee, Nam-Su; Ham, Hae Sun; Kim, Tae-You; Park, Yeon Hee; Lee, Kyung Eun; Kim, Kee Won; Seo, Jae Hong; Lee, Soon Nam; Hong, Young Seon; Bang, Yung-Jue; Kim, Woo-Kun; Park, Hee-Sook Oncology Reports, Vol.14 No.2, pp.481-487	DOI
2008-01	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin Kim, Sun Young; Kim, Hwang Phill; Kim, Yu Jung; Oh, Do Youn; Im, Seock-Ah; Lee, Dongsoon; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue International Journal of Oncology, Vol.32 No.1, pp.89-95	DOI
2008-03	Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells Kim, Hwang-Phill; Han, Sae-Won; Kim, Sung-Hak; Im, Seock-Ah; Oh, Do-Youn; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.7 No.3, pp.607-615	DOI
2009-05	Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer Jung, So-Youn; Han, Wonshik; Lee, Jong Won; Ko, Eunyoung; Kim, Eunkyu; Yu, Jong-Han; Moon, Hyeong-Gon; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Hwang, Ki-Tae; Kim, Sung-Won; Noh, Dong-Young Annals of Surgical Oncology, Vol.16 No.5, pp.1112-1121	DOI
2010-10	How to Overcome Retinal Neuropathy: The Fight against Angiogenesis-related Blindness Jo, Dong Hyun; Kim, Jin Hyoung; Kim, Jeong Hun Archives of Pharmacal Research, Vol.33 No.10, pp.1557-1565	DOI
2011-11	Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma Kim, Min A.; Lee, Hyuk-Joon; Yang, Han-Kwang; Bang, Yung-Jue; Kim, Woo Ho Histopathology, Vol.59 No.5, pp.822-831	DOI
2012-01	Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Baselga, Jose; Cortes, Javier; Kim, Sung-Bae; Im, Seock-Ah; Hegg, Roberto; Im, Young-Hyuck; Roman, Laslo; Pedrini, Jose Luiz; Pienkowski, Tadeusz; Knott, Adam; Clark, Emma; Benyunes, Mark C.; Ross, Graham; Swain, Sandra M. New England Journal of Medicine, Vol.366 No.2, pp.109-119	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-03	Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody Kim, Jun Gyu; Kang, Min Jueng; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Han, Sae-Won; Park, Jong-Wan; Kang, Gyeong Hoon; Kang, Keon Wook; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You PLoS ONE, Vol.7 No.3, p. e0033322	DOI
2012-09	Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer Bang, Yung-Jue Journal of Clinical Gastroenterology, Vol.46 No.8, pp.637-648	DOI
2014-12	HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer Lee, Hee Jin; Seo, An Na; Kim, Eun Joo; Jang, Min Hye; Suh, Koung Jin; Ryu, Han Suk; Kim, Yu Jung; Kim, Jee Hyun; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Park, In Ae; Park, So Yeon American Journal of Clinical Pathology, Vol.142 No.6, pp.755-766	DOI
2016-07	A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumors Doi, Toshihiko; Lee, Kyung-Hun; Kim, Tae-Min; Ohtsu, Atsushi; Kim, Tae Yong; Ikeda, Masafumi; Yoh, Kiyotaka; Stampino, Corrado Gallo; Hirohashi, Tomoko; Suzuki, Akiyuki; Fujii, Yosuke; Williams, James Andrew; Bang, Yung-Jue Cancer Medicine, Vol.5 No.7, pp.1454-1463	DOI
2017-01	HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib Press, Michael F.; Ellis, Catherine E.; Gagnon, Robert C.; Grob, Tobias J.; Buyse, Marc; Villalobos, Ivonne; Liang, Zhiyong; Wu, Shafei; Bang, Yung-Jue; Qin, Shu-Kui; Chung, Hyun Cheol; Xu, Jianming; Park, Joon Oh; Jeziorski, Krzysztof; Afenjar, Karen; Ma, Yanling; Estrada, Monica C.; Robinson, Douglas M.; Scherer, Stefan J.; Sauter, Guido; Hecht, J. Randolph; Slamon, Dennis J. Molecular Cancer Therapeutics, Vol.16 No.1, pp.228-238	DOI
2018-01	Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression Shin, Jun-Seop; Kim, Jong-Min; Min, Byoung-Hoon; Yoon, Il Hee; Kim, Hyun Je; Kim, Jung-Sik; Kim, Yong-Hee; Kang, Seong-Jun; Kim, Jiyeon; Kang, Hee-Jung; Lim, Dong-Gyun; Hwang, Eung-Soo; Ha, Jongwon; Kim, Sang-Joon; Park, Wan Beom; Park, Chung-Gyu Xenotransplantation, Vol.25 No.1, p. e12356	DOI
2018-03	Long-term trastuzumab (Herceptin (R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer Mueller, Volkmar; Clemens, Michael; Jassem, Jacek; Al-Sakaff, Nedal; Auclair, Petra; Nuesch, Eveline; Holloway, Debbie; Shing, Mona; Bang, Yung-Jue BMC Cancer, Vol.18, p. 295	view file DOI
2019-02	Bispecific anti-mPDGFR beta x cotinine scFv-C-kappa-scFv fusion protein and cotinine-duocarmycin can form antibody-drug conjugate-like complexes that exert cytotoxicity against mPDGFR beta expressing cells Kim, Soohyun; Kim, Hyori; Jo, Dong Hyun; Kim, Jeong Hun; Kim, Su Ree; Kang, Dongmin; Hwang, Dobeen; Chung, Junho Methods, Vol.154, pp.125-135	DOI
2019-06	Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea Im, Seock-Ah; Lee, Dae-Won; Kang, Ryungwoo; Kim, Jee Hyun; Kim, Dong-Wan; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Chinese Clinical Oncology, Vol.8 No.3, p. 27	view file DOI
2019-09	Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-positive breast cancer patients Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Jung, Hae Hyun; Park, Woong-Yang; Lee, Kyung-Hun; Sohn, Joohyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee Hyun; Lee, Ki Hyeong; Im, Seock-Ah; Park, Yeon Hee International Journal of Cancer, Vol.145 No.6, pp.1669-1678	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI
2021-04	Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial Rugo, Hope S.; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D.; Wright, Gail S.; Saura, Cristina; Escriva-de-Romani, Santiago; De laurentiis, Michelino; Levy, Christelle; Brown-Glaberman, Ursa; Ferrero, Jean-Marc; de Boer, Maaike; Kim, Sung-Bae; Petrakova, Katarina; Yardley, Denise A.; Freedman, Orit; Jakobsen, Erik H.; Kaufman, Bella; Yerushalmi, Rinat; Fasching, Peter A.; Nordstrom, Jeffrey L.; Bonvini, Ezio; Koenig, Scott; Edlich, Sutton; Hong, Shengyan; Rock, Edwin P.; Gradishar, William J. JAMA oncology, Vol.7 No.4, pp.573-584	DOI
2023-04	Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia Kim, Nak-Hyun; Choi, Yunjung; Kwon, Kyungmi; Park, Jeong Su; Park, Kyoung Un; Moon, Song Mi; Song, Kyoung-Ho; Kim, Eu Suk; Park, Wan Beom; Kim, Hong Bin Journal of Korean Medical Science, Vol.38 No.16, p. e129	DOI